A novel molecular pathway for snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis

Cancer Prevention Research

Volumn 7, Issue 1, 2014, Pages 150-160

  Grant, Jeanette L ^b   Fishbein, Michael C ^b   Hong, Long Sheng ^b   Krysan, Kostyantyn ^a   Minna, John D ^c   Shay, Jerry W ^c   Walser, Tonya C ^a   Dubinett, Steven M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Departments of Pathology and Laboratory Medicine   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 29B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEONECTIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOINFORMATICS; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; PATHOGENESIS; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DISEASE PROGRESSION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; OSTEONECTIN; PHOSPHORYLATION; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84892395815     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0263     Document Type: Article

References (43)

1. Siegel R, Naishadham DA. Cancer statistics, 2013. CA Cancer J Clin 2013;63: 11-30.
2. Heinrich EL, Walser TC, Krysan K, Liclican EL, Grant JL, Rodriguez NL, et al. The inflammatory tumor microenvironment, epithelial-mesenchymal transition, and lung carcinogenesis. Cancer Microenviron 2012;5: 5-18.
3. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 2009;15: 303-7.
4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144: 646-74.
5. Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 2006;66: 5338-45.
6. Horiguchi K, Shirakihara T, Nakano A, Imamura T, Miyazono K, Saitoh M. Role of Ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem 2009;284: 245-53.
7. Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004;24: 306-19.
8. Peinado H, Quintanilla M, Cano A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial-mesenchymal transitions. J Biol Chem 2003;278: 21113-23.
9. Dhasarathy A, Phadke D, Mav D, Shah RR, Wade PA. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS ONE 2011;6:e26514.
10. Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 2011;9: 1658-67.
11. Zheng P, Meng HM, Gao WZ, Chen L, Liu XH, Xiao ZQ, et al. Snail as a key regulator of PRL-3 gene in colorectal cancer. Cancer Biol Ther 2011;12: 742-9.
12. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133: 704-15.
13. Yang Y, Li Y, Wang K, Wang Y, Yin W, Li L. P38/NF-kappaB/Snail pathway is involved in caffeic acid-induced inhibition of cancer stem cells-like properties and migratory capacity in malignant human keratinocyte. PLoS ONE 2013;8:e58915.
14. Ishii G, Hashimoto H, Atsumi N, Hoshino A, Ochiai A. Morphophenotype of floating colonies derived from a single cancer cell has a critical impact on tumor-forming activity. Pathol Int 2013;63: 29-36.
15. Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, et al. Snail promotes CXCR2 ligand-dependent tumor progression in non- small cell lung carcinoma. Clin Cancer Res 2009;15: 6820-9.
16. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981;26: 99-105.
17. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994;8: 163-73.
18. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 2004;92: 679-90.
19. Koukourakis MI, Giatromanolaki A, Brekken RA, Sivridis E, Gatter KC, Harris AL, et al. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res 2003;63: 5376-80.
20. Sato M, Larsen JE, Lee W, Sun H, Shames DS, Dalvi MP, et al. Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. Mol Cancer Res 2013;11: 638-50.
21. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 2004;64: 9027-34.
22. Vaughan MB, Ramirez RD, Wright WE, Minna JD, Shay JW. A threedimensional model of differentiation of immortalized human bronchial epithelial cells. Differentiation 2006;74: 141-8.
23. Minna JD, Girard L, Sato M, Peyton M, Lee W, Shames D, et al. Molecular pathogenesis of lung cancer with translation to the clinic. J Thorac Oncol 2007;2 Suppl 4:S178-S179.
24. Araya J, Cambier S, Markovics JA, Wolters P, Jablons D, Hill A, et al. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest 2007;117: 3551-62.
25. Hazra S, Dubinett SM. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells. Prostaglandins Leukot Essent Fatty Acids 2007;77: 51-8.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25: 402-8.
27. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001;98: 31-6.
28. Olmeda D, Moreno-Bueno G, Flores JM, Fabra A, Portillo F, Cano A. SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Res 2007;67: 11721-31.
29. Shin S, Dimitri CA, Yoon SO, Dowdle W, Blenis J. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motifdependent signaling events. Mol Cell 2010;38: 114-27.
30. Fenouille N, Puissant A, Dufies M, Robert G, Jacquel A, Ohanna M, et al. Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC. Cancer Res 2010;70: 9659-70.
31. Shields MA, Dangi-Garimella S, Krantz SB, Bentrem DJ, Munshi HG. Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase- dependent collagen invasion. J Biol Chem 2011;286: 10495-504.
32. Vicent S, Lopez-Picazo JM, Toledo G, Lozano MD, Torre W, Garcia- Corchon C, et al. ERK1/2 is activated in non-small cell lung cancer and associated with advanced tumours. Br J Cancer 2004;90: 1047-52.
33. Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z. TGF-beta1 induces human alveolar epithelial-to-mesenchymal cell transition (EMT). Respir Res 2005;6:56.
34. Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-betadependent responses in human mesangial cells. FASEB J 2003;17: 1576-8.
35. Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, Decamp MM. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer 2009;115: 1059-69.
36. Sanchez-Garcia I. The crossroads of oncogenesis and metastasis. N Engl J Med 2009;360: 297-9.
37. Varlotto JM, Medford-Davis LN, Recht A, Flickinger J, Yao N, Hess C, et al. Identification of stage I non-small cell lung cancer patients at high risk for local recurrence following sublobar resection. Chest 2013;143: 1365-77.
38. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008;13: 58-68.
39. Podsypanina K, Du YC, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008;321: 1841-4.
40. Dijkman BG, Schuurbiers OC, Vriens D, Looijen-Salamon M, Bussink J, Timmer-Bonte JN, et al. The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours. Eur J Nucl Med Mol Imaging 2010;37: 2037-47.
41. Hung WC, Chen SH, Paul CD, Stroka KM, Lo YC, Yang JT, et al. Distinct signaling mechanisms regulate migration in unconfined versus confined spaces. J Cell Biol 2013;202: 807-24.
42. Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, Aberdam E, et al. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res 2006;66: 7516-23.
43. Atorrasagasti C, Aquino JB, Hofman L, Alaniz L, Malvicini M, Garcia M, et al. SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-beta1 and PDGF. Am J Physiol Gastrointest Liver Physiol 2011;300:G739-48.